HOPO Therapeutics enters Participant Basic Agreement with U.S. Army Contracting Command
Nov 1, 2026
HOPO Therapeutics has entered into a CBRN Medical Countermeasure Participant Basic Agreement (PBA) with U.S. Army Contracting Command, joining a network of partners supporting the Department of War's Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND). The agreement establishes a framework under which HOPO may participate in future Department efforts related to developing medical countermeasures to protect service members against radiological and nuclear threats.
